-
EU vows AI rules will protect Europeans. Will they?
-
KVB Accelerates Middle East Footprint with Strategic MENA Regional Expansion
-
Myanmar leader to visit Malaysia after migrant returns begin
-
Purple reign: Philippines seeks to keep grip on ube throne
-
Germany's AfD poised to preside over state assembly for first time
-
Seoul weighs steps to force North Korea landmine apology
-
Australia's opposition vows 'largest cut to immigration' in country's history
-
Yemen's Houthis say struck Riyadh airport, other Saudi sites
-
Ready, set, snooze: Sleep-deprived Japanese compete for best-rested
-
Changer+ Launches Stablecoin-First Self-Custodial Wallet to Make Stablecoins Easier to Use
-
Falcons thump Saints 45-24 as New Orleans marks Katrina anniversary
-
White Sox down Guardians, Yankees on brink after Rays loss
-
Tuvalu govt adviser says Australia overstepped in pre-COP visit
-
COP31 eyes modest steps as climate disasters multiply
-
Asian stocks mixed despite tech-led Wall St record
-
American Nobel laureate in medicine hopes to illuminate the brain
-
Tens of thousands expected in Paris for high school protests
-
Trump approves firing squad for convicted US military base shooter
-
AI borrowing binge rattles US markets
-
Grappling with 'homework scams,' US universities shun AI detectors
-
Young Canadians sue government over alleged climate failures
-
Separatists win Quebec election in test for Canada PM
-
White Sox down Guardians to take 2-0 series lead
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 06
-
Gold IRA Rules, Taxes, Eligible Metals, RMD and Depositories Explained in New Guide by IRAEmpire
-
Leaders visit Pacific atoll at frontline of climate change
-
NHL record-breaker Ovechkin says current season will be his last
-
Yemen's Houthis claim striking Riyadh airport, other Saudi sites
-
France roar back in Nations League as Italy beat Turkey
-
Best-selling British author Jeffrey Archer dies aged 86
-
Messi readies for final farewell in Argentina send-off
-
Military plane crash kills 32 in Nigeria
-
Esposito seals Italy win over Turkey in Nations League
-
Olise powers France to win over Belgium in Nations League
-
Russia downplays plague reports as Trump offers US help
-
High-flying Blazy turns to birdlife at Chanel
-
Trump says US moved bombers from UK base after 'threats'
-
Riyadh's allies pledge troops as Yemen, Saudi Arabia attack Houthis
-
Brazilian stocks surge to record after Bolsonaro election lead
-
Clashes erupt outside Kosovo parliament over war crimes court
-
Leaders to visit Pacific atoll at frontline of climate change
-
Milan's Saelemaekers suffers ankle setback, faces lengthy spell out
-
ICC gives more details about arrest warrants for Taliban ministers
-
Rubio arrives in Iceland to push for greater US presence in Arctic
-
Nigeria's Tinubu confirms 32 dead after military plane crash
-
Putin allows Italy's UniCredit to sell part of Russian business
-
'Reckless' AI firms can't control models, says whistleblower
-
Djokovic into China Open final as Medvedev out for hitting fan with ball
-
Switching on brain cells: the Nobel-winning science of optogenetics
-
ICC unseals arrest warrants for Taliban education ministers
Fourth person 'cured' of HIV, but is a less risky cure in sight?
AIDS researchers announced on Wednesday that a fourth person has been "cured" of HIV, but the dangerous procedure for patients also battling cancer may be little comfort for the tens of millions living with the virus worldwide.
The 66-year-old man, named the "City of Hope" patient after the Californian centre where he was treated, was declared in remission in the lead up to the International AIDS Conference, which begins in Montreal, Canada on Friday.
He is the second person to be announced cured this year, after researchers said in February that a US woman dubbed the New York patient had also gone into remission.
The City of Hope patient, like the Berlin and London patients before him, achieved lasting remission from the virus after a bone marrow transplant to treat cancer.
Another man, the Duesseldorf patient, has also previously been said to have reached remission, potentially bringing the number cured to five.
Jana Dickter, an infectious disease specialist at the City of Hope, told AFP that because the latest patient was the oldest yet to achieve remission, his success could be promising for older HIV sufferers who also have cancer.
Dickter is the lead author of research on the patient which was announced at a pre-conference in Montreal but has not been peer reviewed.
- 'I am beyond grateful' -
"When I was diagnosed with HIV in 1988, like many others, I thought it was a death sentence," said the patient, who does not want to be identified.
"I never thought I would live to see the day that I no longer have HIV," he said in a City of Hope statement. "I am beyond grateful."
Dickter said the patient had told her of the stigma he experienced during the early days of the AIDS epidemic in the 1980s.
"He saw many of his friends and loved ones become very ill and ultimately succumb to the disease," she said.
He had "full-blown AIDS" for a time, she said, but was part of early trials of antiretroviral therapy, which now allows many of the 38 million with HIV globally to live with the virus.
He had HIV for 31 years, longer than any previous patient who went into remission.
After being diagnosed with leukaemia, in 2019 he received a bone marrow transplant with stem cells from an unrelated donor with a rare mutation in which part of the CCR5 gene is missing, making people resistant to HIV.
He waited until getting vaccinated for Covid-19 in March 2021 to stop taking antiretrovirals, and has been in remission from both HIV and cancer since.
Reduced-intensity chemotherapy worked for the patient, potentially allowing older HIV patients with cancer to get the treatment, Dickter said.
But it is a complex procedure with serious side effects and "isn't a suitable option for most people with HIV", she added.
Steven Deeks, an HIV expert at the University of California, San Francisco who was not involved in the research, said the "first thing you do in a bone marrow transplant is you destroy your own immune system temporarily".
"You would never do this if you didn't have cancer," he told AFP.
- 'Holy Grail' -
Also announced at the AIDS conference was research about a 59-year-old Spanish woman with HIV who has maintained an undetectable viral load for 15 years despite stopping antiretroviral therapy.
Sharon Lewin, president-elect of the International AIDS Society which convenes the conference, said that it was not quite the same as the City of Hope patient, because the virus remained at a very low level.
"A cure remains the Holy Grail of HIV research," Lewin said.
"We have seen a handful of individual cure cases before and the two presented today provide continued hope for people living with HIV and inspiration for the scientific community."
She also pointed to a "truly exciting development" towards identifying HIV in an individual cell, which is "a bit like finding a needle in a haystack".
Deeks, an author of the new research also presented at the conference, said it was an "unprecedented deep dive into the biology of the infected cell".
The researchers identified that a cell with HIV has several particular characteristics.
It can proliferate better than most, is hard to kill, and is both resilient and hard to detect, Deeks said.
"This is why HIV is a lifelong infection."
But he said that cases such as the City of Hope patient offered a potential roadmap towards a more broadly available cure, possibly using CRISPR gene-editing technology.
"I think that if you can get rid of HIV, and get rid of CCR5, the door by which HIV gets in, then you can cure someone," Deeks said.
"It's theoretically possible -- we're not there yet -- to give someone a shot in the arm that will deliver an enzyme that will go into the cells and knock out CCR5, and knock out the virus.
"But that's science fiction for now."
A.Clark--AT